October October
If there is one particular month to deploy cash this would be the month. The SRS Fund was not spared as the traditional blood-letting month lived up to its name bringing the SRS fund back into slight negative territory for the year.
The SRS Fund is down 1.15% year to date versus the STI negative 5.64%. While the fund held onto its lead against the index there is little to celebrate as long-term yield spike during the month threatening to normalise the yield curve.
It was only after the Federal Reserves signaled the likely end to rate hikes that gave much comfort to the market as yields pulled back from their all-time highs. As such, the market began to rally shortly into November with all yield-sensitive stocks like REITs making a strong rebound.
There are however no activities for the SRS Funds in October despite the amount of blood on the street as I aim to start building a reasonable cash buffer for the fund while interest rates remains elevated.
Portfolio Segments
Portfolio allocation remains heavy in the finance sector as the outlook on banks remains much brighter than most other segments. Going forward however cash resources will be allocated towards non finance sector due to this overweighting.
Dividends
A mere $255 of dividend was received in October from SGX. However, I would expect a record Q4 dividend judging by up and coming announced dividends.
SRS Fund Value
The SRS Fund value plummeted to $353,052.28 in the month making this pullback one of the steepest for the fund in the last 5 years.
Cash Levels
Cash level should continue to rise as I start to build up a significant cash buffer with a yield in the range of 4%. My initial cash target for the SRS Fund would be in the region of 10% for cash if no good opportunity arises.
Many investors will be relieved by the sudden change in yield pressure however, I do not see any upcoming interest rate cut anytime soon. Sure inflation should come down somewhat but one should not expect rates to go back down to ultra-low levels like what we have seen in the past 2 decades.
-
The SRS Fund Dec 2025
If someone had told me at the start of the year that the Singapore stock market would deliver returns in excess of 20%, I would have shrugged it off as wishful thinking.
-
MyNest US Fund Dec 25
MyNest US Fund rounded the first year of inception with a slight outperformance to our benchmark the S&P 500. The first year of operation tested to resolve in knowing what we own as we navigated volatility which started on Trump’s Liberation Day.
-
The SRS Fund Nov 2025
If you’ve been watching the Singapore market this past month, the narrative has been impossible to ignore: it is a tale of three banks, and unfortunately for UOB, it has found itself lagging its peers.
-
MyNest US Fund Nov 25
November tested the patience of the broader market, defined by a distinct shift in sentiment regarding Artificial Intelligence. The narrative of an “AI Bubble” finally took hold,
-
The SRS Fund Oct 2025
Many of us in Singapore watch in dismay as interest rates from T-bills, fixed deposits and high-yield bank accounts plummet to new lows in recent months. Three months Sora now stands at 1.29%.
-
MyNest US Fund Oct 25
October is usually the worst month of the year for stocks but somehow this year the stock market failed to provide any opportunities for us to deploy meaningful cash to work.
MYNEST.SG 